Hesperetin

Interstellar grade B

Preclinical: Mechanistic, cell or animal evidence. No single preclinical driver opens a pathway on its own.

Appears on 3 blend pages, each linked below.

Hesperetin, the aglycone freed from orange-peel hesperidin, prompted human artery-lining cells to release nitric oxide and raised their eNOS expression.

What the evidence shows

Every line below is carried on the blend page that makes the claim. Follow it to the pathway and its sources.

Where it appears

3 blend pages carry this ingredient. Open it and you will find this ingredient in the list.

• Lung Power (Respiratory Capacity)
• SIRT1 Activator (Caloric-Restriction Mimetic)
• Victorious (Antiviral Immunity)

Pathways it touches